Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Impact of Smoking Information on Concerns About Radon

17. april 2019 oppdatert av: Paul Windschitl
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk. This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals. Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers. The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded. Two studies were conducted. Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).

Studieoversikt

Detaljert beskrivelse

Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk. This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals. Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers. The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded. Two studies were conducted. Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers). Participants in both studies were recruited through Amazon's Mechanical Turk (MTurk). Participants viewed radon messages that varied in the information they communicated about smoking's effect on lung cancer. In Study 1, smoking information was included or excluded from messages assembled from existing radon pamphlets. In Study 2, versions of a new radon message either excluded smoking information, described smoking as a major cause of lung cancer, or also described smoking's synergistic effect with radon on lung cancer risk. After viewing a radon health message, participants completed a variety of measures. Primary measures assessed respondents' anticipated sense of concern and related reactions if they learned that they/their home had been exposed to elevated levels of radon. Other key measures included questions about participants' interest and intention to test their home for radon.

Studietype

Intervensjonell

Registrering (Faktiske)

1390

Fase

  • Ikke aktuelt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Live within the US
  • Have an Amazon Mechanical Turk account (website where online study was posted)

Exclusion Criteria:

  • None

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Faktoriell oppgave
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Study 1: Radon&Smoking Synergistic/EPA
Participants viewed radon and smoking risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects. This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Aktiv komparator: Study 1: Radon&Smoking Synergistic/Idaho
Participants viewed radon and smoking risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects. This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Eksperimentell: Study 1: Radon Only / EPA
Participants viewed only radon risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure. No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
Eksperimentell: Study 1: Radon Only / Idaho
Participants viewed only radon risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure. No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
Eksperimentell: Study 2: Radon Only
Participants viewed a radon-only message that focused only on the effect of radon on lung-cancer risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure. No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
Annen: Study 2: Radon and Smoking Isolated
Participants viewed a radon-and-smoking-isolated message that covered the individual effects of radon and of smoking on lung cancer, but without mentioning their synergistic effect.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure and smoking. No information describing the synergistic effects of smoking and radon exposure on lung cancer risk are included.
Aktiv komparator: Study 2: Radon & Smoking Synergistic
Participants viewed a radon-and-smoking-synergistic message that covered the individual effects of radon and of smoking but that also included information about their synergistic effect.
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects. This intervention represents the type of information most commonly presented in radon risk communications.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Conditional Concern Composite
Tidsramme: Immediately post-intervention (approx. 1 minute)
Composite formed from 4 conditional questions assessing concern, perceived impact on risk and comparative risk, and threat--if exposed to radon
Immediately post-intervention (approx. 1 minute)
Interest in Testing Composite
Tidsramme: Immediately post-intervention (approx. 2 minutes)
Composite formed from 2 questions assessing importance and intention to test home for radon
Immediately post-intervention (approx. 2 minutes)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Worry Elicited by Health Message
Tidsramme: Immediately post-intervention (approx. 2 minutes)
Single question assessing worry elicited by the health communication material
Immediately post-intervention (approx. 2 minutes)
Likelihood Judgments about Lung Cancer
Tidsramme: Immediately post-intervention (approx. 4 minutes)
Three items assessing perceived likelihood of developing lung cancer
Immediately post-intervention (approx. 4 minutes)
Elect to Leave Email for Raffle
Tidsramme: Immediately post-intervention (approx. 4 minutes)
Participants given option to leave email address in case they won one of the 20 radon kits being raffled (Study 2).
Immediately post-intervention (approx. 4 minutes)
Elect to Read More
Tidsramme: Immediately post-intervention (approx. 4 minutes)
Participants given option to be presented with more information at the end of the session about testing for radon (Study 2).
Immediately post-intervention (approx. 4 minutes)
Concern about Loved Ones If Exposed to Radon
Tidsramme: Immediately post-intervention (approx. 4 minutes)
Rated how concerned they would be about loved ones if they learned their home had high radon (Study 2)
Immediately post-intervention (approx. 4 minutes)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

7. august 2015

Primær fullføring (Faktiske)

22. april 2016

Studiet fullført (Faktiske)

22. april 2016

Datoer for studieregistrering

Først innsendt

30. mars 2018

Først innsendt som oppfylte QC-kriteriene

13. april 2018

Først lagt ut (Faktiske)

17. april 2018

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. april 2019

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. april 2019

Sist bekreftet

1. april 2019

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified data and guide will be made available to other investigators upon request.

IPD-delingstidsramme

Requested data will be made available upon publication of the project.

Tilgangskriterier for IPD-deling

Please contact corresponding author Dr. Paul Windschitl at paul-windschitl@uiowa.edu

IPD-deling Støtteinformasjonstype

  • ANALYTIC_CODE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Radon & Smoking Synergistic

Abonnere